ArticleTranslational vision science & technology2025
Binocular Eye Alignment Monitor (BEAM): Home Monitoring Proof-of-Concept Device to Quantify Binocular Alignment for Intermittent Exotropia.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Objective Assessment of Intermittent Exotropia Magnitude and Control Using the Binocular Eye Alignment Monitor.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Intermittent exotropia (IXT) control is challenging to assess clinically because of the variability inherent to this condition. The Binocular Eye Alignment Monitor (BEAM) is a proof-of-concept device that extends eye alignment monitoring for use at home. This study seeks to determine whether the BEAM is feasible for continuously monitoring eye position to identify differences between participants with normal binocular vision and those with IXT. Methods: An eye tracking system integrated with a custom controller was engineered to measure the magnitude and duration of exodeviation for up to four hours. Twelve participants (six diagnosed with IXT and six with normal binocular vision) completed two separate recordings alongside a clinical sensory motor examination. Results: The BEAM successfully recorded eye alignment for 90 minutes and demonstrated that IXT participants exhibited significantly greater ocular misalignment than participants with normal binocular vision. Conclusions: The BEAM is feasible for assessing the magnitude and frequency of temporal exodeviation in the IXT population over prolonged periods while watching a movie from a distance of 6 m, with the participant seated. Translational Relevance: At-home monitoring to evaluate ocular exodeviation for intermittent exotropic patients is feasible with the BEAM. The BEAM's measurements have the potential to provide objective diagnostic criteria and baseline and outcome assessments for studying the effectiveness of therapeutic interventions in the IXT population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.